Brooks Laboratories Limited (BROOKS.NS)

INR 104.98

(-2.74%)

Long Term Debt Summary of Brooks Laboratories Limited

  • Brooks Laboratories Limited's latest annual long term debt in 2023 was 3.56 Million INR , down -40.8% from previous year.
  • Brooks Laboratories Limited's latest quarterly long term debt in 2024 Q1 was - INR , down 0.0% from previous quarter.
  • Brooks Laboratories Limited reported annual long term debt of 6.02 Million INR in 2022, down -94.06% from previous year.
  • Brooks Laboratories Limited reported annual long term debt of 101.39 Million INR in 2021, down -29.78% from previous year.
  • Brooks Laboratories Limited reported quarterly long term debt of 4.67 Million INR for 2023 Q2, down 0.0% from previous quarter.
  • Brooks Laboratories Limited reported quarterly long term debt of 3.56 Million INR for 2023 FY, down -40.8% from previous quarter.

Annual Long Term Debt Chart of Brooks Laboratories Limited (2023 - 2007)

Historical Annual Long Term Debt of Brooks Laboratories Limited (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 3.56 Million INR -40.8%
2022 6.02 Million INR -94.06%
2021 101.39 Million INR -29.78%
2020 144.4 Million INR 21.06%
2019 119.28 Million INR -13.96%
2018 138.63 Million INR -19.67%
2017 172.58 Million INR 59.72%
2016 108.05 Million INR 3055.7%
2015 3.42 Million INR 0.0%
2014 - INR 0.0%
2013 - INR 0.0%
2012 - INR 0.0%
2011 - INR -100.0%
2010 86.66 Million INR -26.69%
2009 118.2 Million INR -26.41%
2008 160.64 Million INR 30.05%
2007 123.52 Million INR 0.0%

Peer Long Term Debt Comparison of Brooks Laboratories Limited

Name Long Term Debt Long Term Debt Difference
Aarey Drugs & Pharmaceuticals Limited 32.24 Million INR 88.944%
Aarti Drugs Limited 2.75 Billion INR 99.871%
Aarti Pharmalabs Limited 400 Thousand INR -791.25%
Ajanta Pharma Limited 235.2 Million INR 98.484%
Alembic Limited 73.9 Million INR 95.176%
Alkem Laboratories Limited 400 Million INR 99.109%
Alembic Pharmaceuticals Limited 628.8 Million INR 99.433%
AstraZeneca Pharma India Limited 27.83 Million INR 87.193%
Bal Pharma Limited 363.82 Million INR 99.02%
Biofil Chemicals and Pharmaceuticals Limited - INR -Infinity%
Bliss GVS Pharma Limited 355.92 Million INR 98.998%
Bafna Pharmaceuticals Limited 107.53 Million INR 96.685%
Caplin Point Laboratories Limited 9.2 Million INR 61.25%
Divi's Laboratories Limited 20 Million INR 82.175%
Eris Lifesciences Limited 6.54 Billion INR 99.946%
Granules India Limited 689.71 Million INR 99.483%
Ind-Swift Limited 10.09 Billion INR 99.965%
Jagsonpal Pharmaceuticals Limited 75.57 Million INR 95.283%
J. B. Chemicals & Pharmaceuticals Limited 236.4 Million INR 98.492%
Jubilant Pharmova Limited 31.67 Billion INR 99.989%
Kilitch Drugs (India) Limited - INR -Infinity%
Medicamen Biotech Limited 12.55 Million INR 71.605%
Medico Remedies Limited 8.67 Million INR 58.891%
Wockhardt Limited 8.91 Billion INR 99.96%
Orchid Pharma Limited 1.2 Billion INR 99.704%
RPG Life Sciences Limited -30.3 Million INR 111.766%
Shilpa Medicare Limited 5.6 Billion INR 99.936%
Sigachi Industries Limited 265.79 Million INR 98.659%
Solara Active Pharma Sciences Limited 1.17 Billion INR 99.696%
Unichem Laboratories Limited 382.22 Million INR 99.067%
Vaishali Pharma Limited 35.98 Million INR 90.093%
Wanbury Limited 820 Million INR 99.565%
Zydus Lifesciences Limited 251 Million INR 98.58%
FDC Limited 2.46 Million INR -44.566%
Amrutanjan Health Care Limited 13.96 Million INR 74.477%
Bajaj HealthCare Limited 650.34 Million INR 99.452%
Dr. Reddy's Laboratories Limited 5.99 Billion INR 99.94%
Glenmark Life Sciences Limited 147.61 Million INR 97.585%
Ind-Swift Laboratories Limited 111.62 Million INR 96.806%
Laurus Labs Limited 7.98 Billion INR 99.955%
Mangalam Drugs & Organics Limited 133.54 Million INR 97.33%
Nectar Lifesciences Limited 1.4 Billion INR 99.746%
Par Drugs and Chemicals Limited - INR -Infinity%
Hester Biosciences Limited 1.81 Billion INR 99.804%
Ipca Laboratories Limited 5.8 Billion INR 99.939%
Venus Remedies Limited 386.8 Million INR 99.078%
ZIM Laboratories Limited 356 Million INR 98.999%
Aurobindo Pharma Limited 21.34 Billion INR 99.983%
Morepen Laboratories Limited 33.64 Million INR 89.402%
Neuland Laboratories Limited 449.2 Million INR 99.206%
Sequent Scientific Limited 1.42 Billion INR 99.75%
Suven Pharmaceuticals Limited 212.35 Million INR 98.321%
Valiant Laboratories Limited 750.89 Million INR 99.525%
Windlas Biotech Limited 20.18 Million INR 82.334%
Hikal Limited 4.22 Billion INR 99.916%
Innova Captab Limited 2.1 Billion INR 99.831%
Procter & Gamble Health Limited 68.8 Million INR 94.818%
Themis Medicare Limited 267.74 Million INR 98.668%
IOL Chemicals and Pharmaceuticals Limited - INR -Infinity%
Mankind Pharma Limited 325.81 Million INR 98.906%
Glenmark Pharmaceuticals Limited 1.51 Billion INR 99.765%
Sakar Healthcare Limited 549.55 Million INR 99.351%
Albert David Limited 6.01 Million INR 40.741%
Lupin Limited 1.55 Billion INR 99.77%
Gufic Biosciences Limited 1.53 Billion INR 99.768%
Sun Pharmaceutical Industries Limited 13.3 Million INR 73.195%
Lincoln Pharmaceuticals Limited - INR -Infinity%
Syncom Formulations (India) Limited -1.21 Million INR 392.453%
Piramal Enterprises Limited 535.85 Billion INR 99.999%
Torrent Pharmaceuticals Limited 16.04 Billion INR 99.978%
NATCO Pharma Limited 53 Million INR 93.274%
Suven Life Sciences Limited - INR -Infinity%
Krebs Biochemicals & Industries Limited 1.83 Billion INR 99.806%
Strides Pharma Science Limited 6.71 Billion INR 99.947%
Indoco Remedies Limited 3.51 Billion INR 99.899%
Alpa Laboratories Limited - INR -Infinity%
Lasa Supergenerics Limited - INR -Infinity%
Sun Pharma Advanced Research Company Limited 106.6 Million INR 96.656%